R2103578 |
DT2216 |
DT2216 is a potent and selective BCL-XL degrader based on PROTAC technology. SIA
|
R2103579 |
JTZ-951;Enarodustat |
Enarodustat is a potent and orally active factor prolyl hydroxylase inhibitor, w
|
R2103580 |
CBR-5884 |
CBR-5884 is an active, selective inhibitor of phosphoglycerate dehydrogenase (PH
|
R2103581 |
Homo-PROTAC cereblon degrader 1 (compound 15a) |
Homo-PROTAC cereblon degrader 1 (compound 15a) is a highly potent and efficient
|
R2103582 |
RU-301 |
RU-301 is a pan-TAM receptor inhibitor, exerts pan-TAM inhibitory activity by bi
|
R2103583 |
Desmorpholinyl Navitoclax-NH-Me |
Desmorpholinyl Navitoclax-NH-Me is a Bcl-xL inhibitor. Desmorpholinyl Navitoclax
|
R2103584 |
TVB-3664 |
TVB-3664 is an orally available, reversible, potent, selective and highly bioava
|
R2103585 |
VTP50469 |
VTP50469 is a potent, highly selective and orally active Menin-MLL interaction i
|
R2103586 |
G1T28;Trilaciclib |
Trilaciclib is a potential first-in-class short-acting CDK4/6 inhibitor in devel
|
R2103587 |
Trilaciclib hydrochloride (G1T28 hydrochloride) |
Trilaciclib hydrochloride (G1T28 hydrochloride) is a CDK4/6 inhibitor with IC50s
|
R2103588 |
SX682 |
SX-682 is an orally bioavailable, potent allosteric inhibitor of CXCR1 and CXCR2
|
R2103589 |
Mli-2 |
MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0
|
R2103591 |
PT-2399 |
PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-
|
R2103592 |
(Rac)-PT2399 |
(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specif
|
R2103593 |
EGFR-IN-7 (compound 34) |
EGFR-IN-7 (compound 34) is a selective and potent EGFR kinase inhibitor extracte
|
R2103594 |
MSAB |
MSAB is a potent and selective inhibitor of Wnt/β-catenin signaling. MSAB binds
|
R2103595 |
Rogaratinib;BAY1163877 |
Rogaratinib is a potent and selective fibroblast growth factor receptor (FGFR) i
|
R2103553 |
Omadacycline hydrochloride (PTK0796 hydrochloride) |
Omadacycline hydrochloride is novel, aminomethyl tetracycline antibiotic being d
|
R2103590 |
MYF-01-37 |
MYF-01-37 is a novel covalent inhibitor of TEAD.
|
R2061750 |
TAPI-1 |
TAPI-1 is a TACE (ADAM17) inhibitor and blocks the shedding of several
|
R2103596 |
PQR530 |
PQR530 is a potent, ATP-competitive, orally bioavailable and brain-penetrant dua
|
R2103597 |
CD38 inhibitor 1 |
CD38 inhibitor 1 (compound 78c) is a potent CD38 inhibitor with IC50s of 7.3 nM
|
R2103598 |
Olutasidenib |
Olutasidenib (FT-2102) is a highly potent, orally active, brain penetrant and se
|
R2103599 |
PRN1008 |
PRN1008 is a reversible covalent, selective and oral active inhibitor of Bruton’
|
R2103600 |
Allopregnanolone |
Allopregnanolone, a neurosteroid synthesized from progesterone in brain, acts as
|